alzheimer-disease

Documents about alzheimer-disease

• A Machine Learning Approach to Predict Cognitive Decline in Alzheimer Disease Clinical Trials.#123118NCBI PubMed Central
• CognitiveTwin: Robust Multi-Modal Digital Twins for Predicting Cognitive Decline in Alzheimer's Disease#134590arXiv CS
• LASSO-HHO two-stage hybrid gene selection framework for accurate Alzheimer's disease diagnosis.#135738NCBI PubMed Central
• Pathways to resilience: relationships between cognitive reserve, psychological debt, and Alzheimer's disease biomarkers.#136055NCBI PubMed Central
• Characterizing circadian rest-activity rhythm patterns across Alzheimer's disease continuum in Down syndrome.#148152NCBI PubMed Central
• Evidence for bilingualism as a cognitive reserve factor in biomarker-confirmed Alzheimer's disease#148864bioRxiv / medRxiv
• Aberrant Brain Entropy in Alzheimer's Disease: Evidence From a Resting‐State fMRI Study.#150235NCBI PubMed Central
• Shared Genetic Architecture Between Kidney Function and Alzheimer Disease Across Ancestries#157796Unpaywall
• Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum.#159830NCBI PubMed Central
• Natural Microbial Enrichment Modulates Microglial States and Transcriptional Programs Relevant to Alzheimer's Disease#160437bioRxiv / medRxiv
• Multiscale Approximations to Understand the Complex Role of Microglia in Alzheimer's Disease.#170479NCBI PubMed Central
• Single-cell transcriptomic analysis reveals APOE genotype-dependent sex differences in Alzheimer's disease.#174449NCBI PubMed Central
• Treatment of Clinically Diagnosed Alzheimer's Disease by External Counterpulsation A Randomized Clinical Trial.#195990NCBI PubMed Central
• Reconstructing cerebral lymphatic clearance: an emerging target in the Alzheimer's disease therapeutic pipeline.#209325NCBI PubMed Central
• Reframing Alzheimer's disease as a complex adaptive system: More than an amyloid beta–tau connection.#209646NCBI PubMed Central
• Growth hormone-releasing hormone attenuates amyloid deposition and neuroinflammation in Alzheimer's disease models.#213945NCBI PubMed Central
• Longitudinal Spatial Relationships Between Atrophy and Hypometabolism Across the Alzheimer's Disease Continuum.#214235NCBI PubMed Central
• Amyloid plaques drive long-range circuit reorganization in a mouse model of Alzheimer's disease#216643bioRxiv / medRxiv
• The electrophysiological basis of resting-state fMRI hyperconnectivity in early Alzheimer's disease.#221069NCBI PubMed Central
• Investigating the Causal Links between the Aging Process and Alzheimer's Disease Pathogenesis.#242382NCBI PubMed Central
• Is VEGF a key target of cotinine and other potential therapies against Alzheimer disease?#260607Repositorio USS
• Brain Health in Midlife#261383ClinicalTrials.gov
• Transition-Based Digital Twin Modelling for Alzheimer's Disease under Sparse Longitudinal Data#267658arXiv CS
• HSN G1 demonstrates multifaceted therapeutic strategy against Alzheimer disease in APP PS1 mouse model.#288638NCBI PubMed Central
• Choroid plexus remodeling linked to impaired CSF-mediated clearance and Alzheimer's disease progression.#305015NCBI PubMed Central
• SECmeres outperform extracellular vesicles as potential blood RNA biomarkers for Alzheimer's disease.#308705NCBI PubMed Central
• Clinico-biological trajectories stratified by combined tau biomarkers in preclinical Alzheimer's disease.#312389NCBI PubMed Central
• The social value of lecanemab for patients with early Alzheimer's disease in Japan.#312580NCBI PubMed Central
• Marine Lipids and Alzheimer's Disease: Biochemistry, Bioaccessibility/Bioavailability, Metabolism, and Health Effects.#315363NCBI PubMed Central
• Neuroinflammation in Alzheimer's Disease (AD) and Glioblastoma (GBM): Shared Mechanisms and Therapeutic Insights.#315391NCBI PubMed Central
• Passive digital health technologies for Alzheimer's disease screening and diagnosis: a systematic review.#338660NCBI PubMed Central
• A mitochondrial-immune axis drives the transcriptomic transition from brain aging to Alzheimer's disease#339552bioRxiv / medRxiv
• The heat exposure, aging trajectories, and Alzheimer's disease (HEAT-AD) study protocol.#358214NCBI PubMed Central
• Learning patient-specific spatial biomarker dynamics via operator learning for Alzheimer's disease progression.#358472NCBI PubMed Central
• Sex differences in brain glucose metabolism in alzheimer's disease: A voxel-based study.#364600NCBI PubMed Central
• Dietary patterns and Alzheimer's disease: East-west perspectives and future intervention strategies.#364687NCBI PubMed Central
• Mitochondrial Complex I Modulator Restores Network Resilience in Advanced Alzheimer's Disease Through Metabolic Reprogramming#373548bioRxiv / medRxiv
• Grey- and white-matter resilience to tau, cognition and sex in Alzheimer's disease#379854bioRxiv / medRxiv
• Network-based discovery of regulatory drivers of cognitive decline in alzheimer's disease.#380782NCBI PubMed Central
• PICALM regulates a human microglial antigen presentation program in Alzheimer’s disease#387683Europe PMC
• Orexin, Sleep, and Cognition in Alzheimer Disease: Non-REM Oscillatory Activity and Neural Resilience.#388651NCBI PubMed Central
• Cognitive and Neuroimaging Biomarker Intra-Individual Variability in Alzheimer's Disease#394559bioRxiv / medRxiv
• Cross-ancestry polygenic risk scores enhance Alzheimer's disease risk prediction in multiethnic cohorts.#415453NCBI PubMed Central
• Associations of dementia polyexposure scores to Alzheimer's disease endophenotypes in a diverse population.#415611NCBI PubMed Central
• Multiregional single-cell profiling reveals shared and specialized cellular vulnerability in Alzheimer's disease#417353bioRxiv / medRxiv
• Interaction-based metabolomics identifies serum modifiers of the clinical expression of Alzheimer's disease pathology#417393bioRxiv / medRxiv
• Retinal Transcriptome-Wide Association Study Identifies Novel Alzheimer's Disease Risk Genes#419978bioRxiv / medRxiv
• PTP1B inhibition promotes microglial phagocytosis in Alzheimer's disease models by enhancing SYK signaling.#422886NCBI PubMed Central
• Blood-based biomarkers and 20-year risk of clinically diagnosed Alzheimer’s disease#424645Europe PMC
• Cost-effectiveness of testing biofluid biomarkers to diagnose Alzheimer's disease: a systematic review.#440871NCBI PubMed Central